|
1
|
Steinman RM and Banchereau J: Taking
dendritic cells into medicine. Nature. 449:419–426. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sims RB: Development of sipuleucel-T:
Autologous cellular immunotherapy for the treatment of metastatic
castrate resistant prostate cancer. Vaccine. 30:4394–4397. 2012.
View Article : Google Scholar
|
|
3
|
Montagna D, Turin I, Schiavo R, et al:
Feasibility and safety of adoptive immunotherapy with ex
vivo-generated autologous, cytotoxic T lymphocytes in patients with
solid tumor. Cytotherapy. 14:80–90. 2012. View Article : Google Scholar
|
|
4
|
Narita M, Watanabe N, Yamahira A, et al: A
leukemic plasmacytoid dendritic cell line, PMDC05, with the ability
to secrete IFN-alpha by stimulation via Toll-like receptors and
present antigens to naive T cells. Leuk Res. 33:1224–1232. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watanabe N, Narita M, Yamahira A, et al:
Transformation of dendritic cells from plasmacytoid to myeloid in a
leukemic plasmacytoid dendritic cell line (PMDC05). Leuk Res.
34:1517–1524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamahira A, Narita M, Nakamura T, et al:
Generation of antigen-specific cytotoxic T lymphocytes using a
leukemic plasmacytoid dendritic cell line as antigen presenting
cells. Leuk Res. 35:793–799. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamahira A, Narita M, Ishii K, et al:
Enhancement of antigen presenting ability in the leukemic
plasmacytoid dendritic cell line (PMDC05) by lentiviral
vector-mediated transduction of CD80 gene. Leuk Res. 36:1541–1546.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stripecke R: Lentiviral vector-mediated
genetic programming of mouse and human dendritic cells. Methods Mol
Biol (Clifton, NJ). 506:139–158. 2009.
|
|
9
|
Pincha M, Salguero G, Wedekind D, et al:
Lentiviral vectors for induction of self-differentiation and
conditional ablation of dendritic cells. Gene Ther. 18:750–764.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi M, Shigeno N, Takahashi H, et
al: Effects of transfection of p210bcr-abl and bcr-v-abl into the
factor-dependent human leukemia cell line HSM-911. Leuk Res.
21:1115–1123. 1997. View Article : Google Scholar
|
|
11
|
Narita M, Masuko M, Kurasaki T, Kitajima
T, Takenouchi S, Saitoh A, Watanabe N, Furukawa T, Toba K, Fuse I,
Aizawa Y, Kawakami M, Oka Y, Sugiyama H and Takahashi M: WT1
peptide vaccination in combination with imatinib therapy for a
patient with CML in chronic phase. Int J Med Sci. 7:72–81. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamanaka R, Homma J, Yajima N, et al:
Clinical evaluation of dendritic cell vaccination for patients with
recurrent glioma: Results of a clinical phase I/II trial. Clin
Cancer Res. 11:4160–4167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Irvine DJ and Doh J: Synthetic surfaces as
artificial antigen presenting cells in the study of T cell receptor
triggering and immunological synapse formation. Semin Immunol.
19:245–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koffeman E, Keogh E, Klein M, Prakken B
and Albani S: Identification and manipulation of antigen specific
T-cells with artificial antigen presenting cells. Methods Mol Med.
136:69–86. 2007.PubMed/NCBI
|
|
15
|
Rudolf D, Silberzahn T, Walter S, et al:
Potent costimulation of human CD8 T cells by anti-4-1BB and
anti-CD28 on synthetic artificial antigen presenting cells. Cancer
Immunol Immunother. 57:175–183. 2008. View Article : Google Scholar
|
|
16
|
Steenblock ER, Wrzesinski SH, Flavell RA
and Fahmy TM: Antigen presentation on artificial acellular
substrates: modular systems for flexible, adaptable immunotherapy.
Expert Opin Biol Ther. 9:451–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai Z, Brunmark A, Jackson MR, Loh D,
Peterson PA and Sprent J: Transfected Drosophila cells as a probe
for defining the minimal requirements for stimulating unprimed
CD8+ T cells. Proc Natl Acad Sci USA. 93:14736–14741.
1996. View Article : Google Scholar
|
|
18
|
Hasan AN, Kollen WJ, Trivedi D, et al: A
panel of artificial APCs expressing prevalent HLA alleles permits
generation of cytotoxic T cells specific for both dominant and
subdominant viral epitopes for adoptive therapy. J Immunol.
183:2837–2850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Papanicolaou GA, Latouche JB, Tan C, et
al: Rapid expansion of cytomegalovirus-specific cytotoxic T
lymphocytes by artificial antigen-presenting cells expressing a
single HLA allele. Blood. 102:2498–2505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan J, Gallardo HF, Rasalan T, et al: In
vitro expansion of Ag-specific T cells by HLA-A*0201-transfected
K562 cells for immune monitoring. Cytotherapy. 8:498–508. 2006.
View Article : Google Scholar
|
|
21
|
Butler MO, Lee JS, Ansén S, et al:
Long-lived antitumor CD8+ lymphocytes for adoptive
therapy generated using an artificial antigen-presenting cell. Clin
Cancer Res. 13:1857–1867. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sasawatari S, Tadaki T, Isogai M, Takahara
M, Nieda M and Kakimi K: Efficient priming and expansion of
antigen-specific CD8+ T cells by a novel cell-based
artificial APC. Immunol Cell Biol. 84:512–521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaperot L, Blum A, Manches O, et al:
Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of
plasmacytoid dendritic cells. J Immunol (Baltimore, Md. 150). 176.
pp. 248–255. 2006
|
|
24
|
Di Domizio J, Blum A, Gallagher-Gambarelli
M, Molens JP, Chaperot L and Plumas J: TLR7 stimulation in human
plasmacytoid dendritic cells leads to the induction of early
IFN-inducible genes in the absence of type I IFN. Blood.
114:1794–1802. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maeda T, Murata K, Fukushima T, et al: A
novel plasmacytoid dendritic cell line, CAL-1, established from a
patient with blastic natural killer cell lymphoma. Int J Hematol.
81:148–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sapienza MR, Fuligni F, Agostinelli C, et
al: Molecular profiling of blastic plasmacytoid dendritic cell
neoplasm reveals a unique pattern and suggests selective
sensitivity to NF-κB pathway inhibition. Leukemia: official journal
of the Leukemia Society of America; Leukemia Research Fund, U.K.:
2014
|
|
27
|
Aspord C, Charles J, Leccia MT, et al: A
novel cancer vaccine strategy based on HLA-A*0201 matched
allogeneic plasmacytoid dendritic cells. PLoS ONE. 5:e104582010.
View Article : Google Scholar
|
|
28
|
Stone AE, Giugliano S, Schnell G, et al:
Hepatitis C virus pathogen associated molecular pattern (PAMP)
triggers production of lambda-interferons by human plasmacytoid
dendritic cells. PLoS Pathogens. 9:e10033162013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Narita M, Kuroha T, Watanabe N, et al:
Plasmacytoid dendritic cell leukemia with potent antigen-presenting
ability. Acta Haematol. 120:91–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cisco RM, Abdel-Wahab Z, Dannull J, et al:
Induction of human dendritic cell maturation using transfection
with RNA encoding a dominant positive toll-like receptor 4. J
Immunol (Baltimore, Md. 1950). 172:7162–7168. 2004. View Article : Google Scholar
|
|
31
|
Abdel-Wahab Z, Cisco R, Dannull J, et al:
Cotransfection of DC with TLR4 and MART-1 RNA induces
MART-1-specific responses. J Surg Res. 124:264–273. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonehill A, Tuyaerts S, Van Nuffel AM, et
al: Enhancing the T-cell stimulatory capacity of human dendritic
cells by co-electroporation with CD40L, CD70 and constitutively
active TLR4 encoding mRNA. Mol Ther. 16:1170–1180. 2008. View Article : Google Scholar : PubMed/NCBI
|
